Bandhan BSE Healthcare Index Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.09%)Nav, as on 17-09-2025

  • Previous Nav

  • Net Change on 17-09-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Motilal Oswal Nifty Midcap 150 Index Fund - Regular Plan Sep 06, 2019 -2.46 21.75 26.04 1.00 2,502.39
Motilal Oswal Nifty 500 Index Fund - Regular Plan Sep 06, 2019 -2.30 15.21 19.29 0.88 2,427.10
DSP Nifty 50 Equal Weight Index Fund - Regular Plan - Growth Oct 23, 2017 -1.07 16.97 22.29 0.92 2,234.55
Axis Nifty 100 Index Fund - Regular Plan - Growth Option Oct 18, 2019 -1.79 13.15 17.22 0.92 1,903.34
Motilal Oswal Nifty Smallcap 250 Index - Regular Plan Sep 06, 2019 -6.76 21.80 26.41 1.04 965.27

Fund Holdings as on 31-August-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Max Healthcare Institute Limited

  • Divi's Laboratories Limited

  • Dr. Reddy's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Laurus Labs Limited

  • Glenmark Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Alkem Laboratories Limited

  • Mankind Pharma Limited

  • Zydus Lifesciences Limited

  • Biocon Limited

  • IPCA Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Cohance Lifesciences Limited

  • Abbott India Limited

  • Gland Pharma Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Aster DM Healthcare Limited

  • Dr. Lal Path Labs Limited

  • Syngene International Limited

  • Wockhardt Limited

  • Narayana Hrudayalaya Limited

  • Neuland Laboratories Limited

  • Global Health Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Piramal Pharma Limited

  • Ajanta Pharma Limited

  • Concord Biotech Limited

  • Poly Medicure Limited

  • Jubilant Pharmova Limited

  • Pfizer Limited

  • Natco Pharma Limited

  • Rainbow Childrens Medicare Limited

  • Eris Lifesciences Limited

  • Granules India Limited

  • Acutaas Chemicals Limited

  • Metropolis Healthcare Limited

  • Strides Pharma Science Limited

  • Sai Life Sciences Limited

  • AstraZeneca Pharma India Limited

  • Jupiter Life Line Hospitals Limited

  • Alembic Pharmaceuticals Limited

  • Procter & Gamble Health Limited

  • Vijaya Diagnostic Centre Limited

  • Sanofi Consumer Healthcare India Limited

  • Sanofi India Limited

  • Shilpa Medicare Limited

  • Aarti Pharmalabs Limited

  • Indegene Limited

  • Caplin Point Laboratories Limited

  • Marksans Pharma Limited

  • Emcure Pharmaceuticals Limited

  • Kovai Medical Center and Hospital Limited

  • Alivus Life Sciences Limited

  • Healthcare Global Enterprises Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • FDC Limited

  • Triparty Repo TRP_010925

  • Sequent Scientific Limited

  • Thyrocare Technologies Limited

  • Indraprastha Medical Corporation Limited

  • Solara Active Pharma Sciences Limited

  • Dishman Carbogen Amcis Limited

  • Supriya Lifescience Limited

  • Morepen Laboratories Limited

  • Aarti Drugs Limited

  • Advanced Enzyme Technologies Limited

  • Blue Jet Healthcare Ltd

  • Krsnaa Diagnostics Limited

  • Innova Captab Limited

  • Suven Life Sciences Limited

  • Sun Pharma Advanced Research Company Limited

  • Akums Drugs and Pharmaceuticals Limited

  • Gujarat Themis Biosyn Limited

  • Orchid Pharma Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Unichem Laboratories Limited

  • Bliss GVS Pharma Limited

  • Senores Pharmaceuticals Limited

  • RPG Life Sciences Limited

  • Gufic Biosciences Limited

  • Indoco Remedies Limited

  • Vimta Labs Limited

  • Hikal Limited

  • Windlas Biotech Limited

  • Syncom Formulations India Limited

  • Hester Biosciences Limited

  • Artemis Medicare Services Limited

  • SMS Pharmaceuticals Limited

  • Novartis India Limited

  • Suraksha Diagnostic Limited

  • Sigachi Industries Limited

  • Shalby Limited

  • Lincoln Pharmaceuticals Limited

  • Tarsons Products Limited

  • Kopran Limited

  • GPT Healthcare Limited

  • Themis Medicare Limited

  • KMC Speciality Hospitals (India) Limited

  • NGL Fine Chem Limited

  • Sastasundar Ventures Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Trading

  • Plastic Products

  • Chemicals

  • Finance - NBFC

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Bandhan BSE Healthcare Index Fund

Scheme Analysis

Bandhan BSE Healthcare Index Fund is a Index Funds - Other fund and belongs to Bandhan Mutual Fund. It was launched on 06-Sep-2024 and currently has an AUM of ₹18.29 crore. Bandhan BSE Healthcare Index Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Bandhan BSE Healthcare Index Fund ended down ₹-0.01(-0.09%)yesterday to ₹10.2343.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Bandhan BSE Healthcare Index Fund is managed by Abhishek Jain .

Fund House Contact

6th Floor, One World Centre, 841, Jupiter Mills Compound, Senapati Bapat Marg, Elphinstone Road (West), Mumbai - 400 013

022-66289999
022-24215052